Anfield Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,470
Closed -$29K 196
2019
Q4
$29K Buy
+1,470
New +$29K 0.01% 240